D. Marez et al., A NOVEL CYP2D6 ALLELE WITH AN ABOLISHED SPLICE RECOGNITION SITE ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPE, Pharmacogenetics, 5(5), 1995, pp. 305-311
A novel loss-of function allele of the CYP2D6 gene was characterized i
n a PM individual using exon-by-exon PCR-SSCP analysis. This allele, w
e termed CYP2D6(F), harbours four mutations including a new mutation (
D6-F) which abolishes the splice acceptor site of the Ist intron and r
esults in a premature stop codon, DNA samples from a large population
of healthy unrelated volunteers were tested for D6-F using a PCR-assay
we developed for the specific identification of the mutation in genom
ic DNA. The prevalence of D6-F was very low. However, its identificati
on combined with that of the previously reported gene inactivating mut
ations would further increase the phenotype prediction rate by genotyp
ing.